Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 6/20 | 0.42 |
| ▸ | ACACA | Q13085 | 6/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.32 |
| ▸ | GRM1 | Q13255 | 4/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13096250 | 0.91 | ACACB (0.50) | ACACBACACACHRM2CHRM4CHRM5 | |
| SCHEMBL13288540 | 0.85 | ACACB (0.50) | ACACBACACAGRM1BACE1 | |
| SCHEMBL13960143 | 0.84 | ACACB (0.45) | ACACBACACA | |
| SCHEMBL13096247 | 0.83 | ACACB (0.38) | ACACBACACAGRM1 | |
| SCHEMBL13070822 | 0.83 | ACACB (0.48) | ACACBACACAGRM1BACE1 | |
| SCHEMBL14490553 | 0.83 | ACACB (0.46) | ACACBACACABACE1 | |
| SCHEMBL13105612 | 0.82 | ACACB (0.38) | ACACBACACAGRM1 | |
| SCHEMBL13960142 | 0.82 | ACACB (0.42) | ACACBACACAGRM1BACE1 | |
| SCHEMBL14129223 | 0.82 | ACACB (0.45) | ACACBACACAGRM1BACE1 | |
| SCHEMBL14372083 | 0.81 | ACACB (0.52) | ACACBACACAGRM1BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8383853-B2 | Method for preparing 2,6-diethyl-4-methylphenylacetic acid | BAYER CROPSCIENCE AG (DE) | 2013-02-26 | — | — | US | disclosed |
| US-20100261934-A1 | Method for Preparing 2,6-Diethyl-4-Methylphenylacetic Acid | BAYER CROPSCIENCE AG (DE) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261934-A1 | Method for Preparing 2,6-Diethyl-4-Methylphenylacetic Acid | DDT, TET1, DDC | ACACB 728/4885ACACA 1106/4885CHRM2 122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.